ROSELAND, N.J., March 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced sales of CompuFlo® Epidural disposables to Omaha Pain Physicians, a comprehensive medical pain management center in Omaha, NE. Omaha Pain Physicians is focused on treating patients with acute and chronic pain. Adoption of the technology by this clinic follows a successful eva ...

ROSELAND, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announces it has commenced direct sales of its STA Single Tooth Anesthesia System® (STA) with Meridian Endo & Perio, a large endodontics, periodontics and implant dentistry practice with three offices in Wisconsin. Dr. Lisa Teel, periodontist and implant surgeon with Meridian Endo and Perio, stated, "Our pra ...

ROSELAND, N.J., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided the following letter to shareholders from the Company's CEO, Arjan Haverhals, including updates regarding commercialization of the CompuFlo® technology and initial reimbursements of CompuFlo by commercial payors and Medicare: To our valued shareholders, While we recognize commercializing a new medic ...

Milestone Scientific Inc. (NYSE:MLSS) Q3 2023 Earnings Conference Call November 15, 2023 8:30 AM ET Company Participants David Waldman - IR Jan Haverhals - CEO Keisha Harcum - Controller Conference Call Participants Jeremy Pearlman - Maxim Group Operator Greetings, and welcome to Milestone Scientific's Third Quarter 2023 Financial Results and Business Update Conference Call. At this time, all participants have been placed in a listen-only mode, and the floor will be opened for questions following the presen ...

DOCUMENTS INCORPORATED BY REFERENCE None 1 | UNITED STATES | | | | --- | --- | --- | | SECURITIES AND EXCHANGE COMMISSION | | | | Washington, D.C. 20549 | | | | FORM 10-Q | | | | ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | (Mark One) | | For the quarter ended September 30, 2023 | | | | ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | | | For the transition period from to | | | | Commission file number 001-14053 | | ...

Milestone Scientific Inc. (NYSE:MLSS) Q2 2023 Earnings Conference Call August 15, 2023 8:30 AM ET Company Participants David Waldman - Investor Relations Arjan Haverhals - Chief Executive Officer Peter Milligan - Chief Financial Officer Conference Call Participants Anthony Vendetti - Maxim Group Tucker Andersen - Above All Advisors Operator Greetings, and welcome to the Milestone Scientific Second Quarter 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a lis ...

1 MILESTONE SCIENTIFIC INC. Form 10-Q TABLE OF CONTENTS PART I—FINANCIAL INFORMATION | Item 1. | Condensed Consolidated Financial Statements | | | --- | --- | --- | | | Balance Sheets as of June 30, 2023 (Unaudited) and December 31, 2022 | 4 | | | Statements of Operations for the three and six months ended June 30, 2023 and 2022 (Unaudited) | 5 | | | Statements of Changes in Stockholders' Equity for the three and six months ended June 30, 2023 and 2022 (Unaudited) | 6 | | | Statements of Cash Flows for the ...

Milestone Scientific Inc. (NYSE:MLSS) Q1 2023 Earnings Conference Call May 10, 2023 8:30 AM ET Company Participants David Waldman – Investor Relations Arjan Haverhals – Chief Executive Officer Peter Milligan – Chief Financial Officer Conference Call Participants Anthony Vendetti – Maxim Group Operator Good morning, everyone. And welcome to Milestone Scientific’s First Quarter 2023 Financial Results and Business Update Conference Call. [Operator Instructions] Please note, this conference is being recorded. I ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2023 ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14053 Milestone Scientific Inc. (Exact name of registrant as specified in its charter) Delaware 13-3545623 State or other jurisdiction of Inco ...

Milestone Scientific Inc. (NYSE:MLSS) Q4 2022 Results Conference Call March 31, 2023 8:30 AM ET Company Participants David Waldman - Investor Relations Arjan Haverhals - Chief Executive Officer Peter Milligan - Chief Financial Officer of Milestone Scientifi Conference Call Participants Anthony Vendetti - Maxim Group Mike Pfeffer - Oppenheimer Operator Greetings. Welcome to the Milestone Scientific 2022 Year-end Financial Results and Business Update Conference Call. At this time, all participants have been p ...